Bioidentical Hormone Therapy (BHRT): Benefits, Risks, and Who It’s For

Bioidentical hormone replacement therapy (BHRT) treats menopause symptoms and confirmed hormone deficiency with estradiol, progesterone and testosterone that are chemically identical to the hormones the human body makes. Several bioidentical products are FDA approved, while custom compounded versions are not, and the Endocrine Society (2016) found no evidence that compounded hormones are safer or more effective than FDA-approved hormone therapy.

The main benefits of bioidentical hormones are relief of hot flashes, night sweats and vaginal dryness, and protection against bone loss. The main risks depend on the route and the progestogen: oral estrogen raises blood clot risk while transdermal estradiol does not appear to, and micronized progesterone has looked kinder to breast tissue than synthetic progestins in the French E3N cohort.

Bioidentical Hormone Therapy: What It Actually Is (and Isn’t)

If you’ve spent any time researching hormone replacement, you’ve probably run into the term “bioidentical.” It gets thrown around a lot in wellness circles, sometimes with a marketing spin that makes it hard to separate fact from hype.

Bioidentical hormones are hormones that are structurally identical to the ones your body naturally produces. We’re talking about the same molecular shape, the same chemical formula. Your body can’t tell the difference between bioidentical estradiol and the estradiol your ovaries made at age 25, because there is no difference at the molecular level.

That distinction matters for safety, for dosing and for what you pay. The sections below cover how BHRT differs from conventional hormone replacement, the delivery methods available, what the research shows, and how to judge whether it fits your situation. BHRT is a subset of hormone replacement therapy, the broader category that also includes synthetic and animal-derived hormones.

What Is Bioidentical Hormone Replacement Therapy Used For?

Bioidentical hormone replacement therapy is used mainly for symptoms of perimenopause and menopause: hot flashes, night sweats, disrupted sleep, mood changes and the vaginal and urinary changes now grouped as genitourinary syndrome of menopause. It is also used to prevent bone loss after menopause and to replace hormones in premature ovarian insufficiency.

In men, bioidentical testosterone is the standard form of testosterone replacement therapy (TRT) for confirmed hypogonadism. Clinics also offer BHRT for fatigue, weight gain, low libido and brain fog, but those uses rest on much thinner evidence unless a hormone deficiency is documented on repeated blood tests.

Readers coming to BHRT from menopause symptoms often also look at non-hormonal and hormonal menopause treatment options, and at vaginal estrogen for atrophic vaginitis.

BHRT vs. Conventional HRT: What’s the Real Difference?

Conventional hormone replacement therapy (HRT) has been around since the 1940s. The most well-known version, Premarin, is conjugated equine estrogen, meaning it’s derived from pregnant mare urine. It contains estrogens, yes, but many of them are horse estrogens that don’t exist naturally in the human body. Provera (medroxyprogesterone acetate) is a synthetic progestin, a molecule that acts on progesterone receptors but isn’t the same molecule your body makes.

Bioidentical hormones, by contrast, are synthesized in a lab from plant precursors (usually wild yam or soy) and then processed until they match human hormones exactly. Eating wild yam or applying wild yam cream does not produce progesterone in the body, because the conversion only happens in a laboratory. The key players include:

• Estradiol (E2): The most potent and dominant estrogen in premenopausal women.
• Estriol (E3): A weaker estrogen sometimes used in combination with estradiol.
• Progesterone: Micronized, identical to what the corpus luteum produces.
• Testosterone: Used in both men and women for optimization.
• DHEA: A precursor hormone that converts into estrogen and testosterone.

Here’s an important nuance: “bioidentical” doesn’t automatically mean “compounded.” Several FDA-approved medications are bioidentical. Estrace (oral estradiol), Vivelle-Dot (estradiol patch), and Prometrium (micronized progesterone) are all bioidentical and go through the same regulatory process as any other pharmaceutical. The distinction between FDA-approved bioidenticals and custom-compounded bioidenticals is one we’ll revisit later, because it’s clinically significant.¹

How do FDA-approved and compounded bioidentical hormones compare?

FDA-approved bioidentical hormones and compounded bioidentical hormones contain the same molecules but differ in oversight, dose consistency and labeling. The table summarizes the differences described by the Endocrine Society (2016) and the North American Menopause Society (2017).

Delivery Methods: How BHRT Gets Into Your System

One of the advantages of BHRT is the range of delivery options. How a hormone enters your bloodstream changes its safety profile, effectiveness, and side effects in meaningful ways.

Pellet Implants

Small, rice-grain-sized pellets are inserted under the skin (usually in the hip or upper buttock) during a quick in-office procedure. They release a steady dose of hormone over 3 to 6 months. Pellets are popular because they provide consistent blood levels without the daily hassle of applying a cream or remembering a pill. The downsides: once they’re in, you can’t easily adjust the dose if side effects emerge, and the procedure needs to be repeated several times a year.²

Testosterone pellets for men have FDA approval, but estradiol pellets and combined estradiol and testosterone pellets for women are compounded products. The Endocrine Society statement by Santoro and colleagues (2016) raised concerns that compounded pellets can push hormone levels above the normal physiologic range.

Topical Creams and Gels

Applied to the skin daily, usually on the inner arm, thigh, or behind the knee. Creams and gels are easy to adjust since you can change the amount you apply. Absorption can vary based on skin thickness, sweating, and whether you’ve recently showered. There’s also a risk of transference to partners, children, or pets through skin contact.

Compounded progesterone creams deserve a specific caution. Skin absorption of progesterone is unreliable, and a cream may not deliver enough to protect the uterine lining from estrogen, which is why approved guidance favors oral micronized progesterone for women who still have a uterus.

Transdermal Patches

Patches deliver a consistent dose through the skin and bypass the liver entirely. This is clinically important: oral estrogens pass through the liver first (the “first pass effect”), which increases production of clotting factors. Transdermal estradiol does not appear to carry the same clotting risk, making patches a safer option for women with elevated cardiovascular risk.³

Oral Tablets and Capsules

Oral micronized progesterone (Prometrium) is well-studied and effective. Oral estradiol is also available, though most clinicians now prefer transdermal estrogen due to the clotting concern. Oral testosterone is less commonly prescribed, though newer formulations like Jatenzo (testosterone undecanoate) have been approved for men.

Vaginal Preparations

Low-dose vaginal estradiol (creams, rings, tablets) treats local symptoms like vaginal dryness and urinary issues with minimal systemic absorption. These are among the safest hormone preparations available and are often appropriate even for women who can’t take systemic HRT.⁴

What the Evidence Shows: Benefits of BHRT

The benefits of bioidentical hormone therapy are best documented for menopause symptoms, bone density and confirmed male hypogonadism. Evidence for heart, brain and mood benefits is weaker and mostly observational.

Menopause Symptom Relief

This is the most well-established benefit. Bioidentical estradiol effectively reduces hot flashes, night sweats, sleep disruption, vaginal dryness, and mood changes. Multiple randomized trials confirm that estradiol, whether delivered by patch, gel, or pellet, significantly reduces vasomotor symptoms compared to placebo. The relief is usually noticeable within a few weeks, with full effect by 8 to 12 weeks.⁵

A Cochrane review by MacLennan and colleagues (2004) found that oral estrogen therapy, alone or with a progestogen, substantially reduced the frequency and severity of hot flushes compared with placebo. For a wider comparison of hormone types for menopause, see our guide to choosing HRT for menopause.

Bone Protection

Estrogen is the primary regulator of bone metabolism in women. When estrogen drops at menopause, bone loss accelerates. BHRT with estradiol maintains bone mineral density and reduces fracture risk. The Women’s Health Initiative (WHI) confirmed this benefit even while raising concerns about other risks. For women at high fracture risk who can’t tolerate bisphosphonates, HRT remains a valid option.⁶

Cardiovascular Considerations

The relationship between HRT and heart health is complex. The “timing hypothesis” suggests that estrogen started within 10 years of menopause onset, or before age 60, may be cardioprotective. Women in this window showed reduced coronary artery calcium scores and lower cardiovascular events in the WHI’s younger cohort analysis. Transdermal estradiol in particular does not appear to increase clotting risk the way oral estrogens do.³

Hormone therapy is not prescribed to prevent heart disease. The North American Menopause Society (2017) treats any heart benefit in younger women as a possible bonus, not a reason to start.

Testosterone Optimization in Men

For men with clinically low testosterone (hypogonadism), bioidentical testosterone, delivered via injections, pellets, or topical gels, restores energy, libido, muscle mass, mood, and cognitive sharpness. Testosterone pellets and injectable testosterone cypionate are both bioidentical. The evidence for testosterone replacement in men with confirmed deficiency is strong, with benefits for body composition, sexual function, bone density, and quality of life.⁷

The Endocrine Society guideline by Bhasin and colleagues (2018) recommends diagnosing hypogonadism only with consistent symptoms and unequivocally low morning testosterone on at least two separate tests. Common signs are covered in our post on low testosterone symptoms, and clinics offering men’s hormone care are listed in the TRT clinic directory.

Testosterone in Women

This is an area where clinical practice is ahead of regulatory approvals. There are no FDA-approved testosterone products for women, yet the evidence for low-dose testosterone in postmenopausal women with hypoactive sexual desire is solid. A global consensus statement from the International Menopause Society supports transdermal testosterone for this indication. Benefits include improved libido, arousal, and orgasmic function.⁸

The same consensus statement by Davis and colleagues (2019) found insufficient evidence to support testosterone for women’s mood, energy, cognition or bone health, and advised dosing that keeps blood levels within the normal premenopausal female range.

Cognitive and Mood Benefits

Estrogen receptors are abundant in the brain, particularly in areas involved in memory and emotional regulation. Observational data suggests that women who start HRT early in menopause have lower rates of Alzheimer’s disease. Progesterone (but not synthetic progestins) appears to have neuroprotective properties. These findings are promising but need more randomized trial confirmation.

The Risk Conversation: What You Need to Know

The risks of bioidentical hormone replacement therapy are the same as the risks of the hormones it contains: blood clots and stroke with oral estrogen, endometrial cancer with estrogen taken alone by women who have a uterus, and a possible breast cancer signal that depends on the progestogen. Compounded products add a separate risk, which is uncertain dosing.

The Breast Cancer Debate

This is the question that keeps coming up, so let’s address it directly. The WHI study found an increased breast cancer risk in women taking conjugated equine estrogen plus medroxyprogesterone acetate (a synthetic progestin). But the estrogen-only arm of the WHI actually showed a decreased breast cancer risk.

The type of progestogen matters enormously. The French E3N cohort study, which followed over 80,000 women, found that micronized progesterone (the bioidentical form) did not increase breast cancer risk when combined with estrogen, while synthetic progestins did.⁹ This doesn’t mean the risk is zero, but it does mean that lumping all HRT together as “cancer-causing” ignores critical differences in formulation.

E3N is an observational cohort, not a randomized trial, and no large randomized trial has tested micronized progesterone head to head against synthetic progestins for breast cancer. Treat the finding as encouraging rather than settled.

Endometrial Protection

Women who still have a uterus need a progestogen alongside systemic estrogen, because estrogen alone thickens the uterine lining and raises the risk of endometrial hyperplasia and cancer. Oral micronized progesterone is the bioidentical option with trial data for this purpose. Any bleeding after menopause needs evaluation; see our page on postmenopausal bleeding.

Blood Clots and Stroke

Oral estrogens increase the liver’s production of clotting factors, raising the risk of deep vein thrombosis and pulmonary embolism. Transdermal estradiol bypasses the liver and does not appear to carry this risk. A large French study (the ESTHER study) confirmed that transdermal estradiol was not associated with increased venous thromboembolism, while oral estrogen was.³

For women with a history of blood clots, clotting disorders, or obesity, transdermal delivery is strongly preferred.

Compounded BHRT: A Word of Caution

Compounding pharmacies create custom hormone preparations, often combining multiple hormones in specific ratios. While compounding serves a legitimate medical purpose (for patients who need non-standard doses or are allergic to certain fillers), it also operates with less regulatory oversight than FDA-approved products.

Compounded hormones do not undergo the same rigorous testing for potency, purity, and consistency. Some studies have found significant dose variability between batches.¹⁰ If an FDA-approved bioidentical option exists that meets your needs, that’s generally the more reliable choice. If compounding is necessary, work with a pharmacy that follows USP (United States Pharmacopeia) standards and submits to voluntary third-party testing.

A 2020 report from the National Academies of Sciences, Engineering, and Medicine reached a similar conclusion, finding insufficient evidence to support the clinical utility of compounded bioidentical hormones for most patients. Saliva testing to set compounded doses is a related red flag: the Endocrine Society (2016) notes that salivary hormone levels do not reliably track blood levels or symptoms.

What Are the Side Effects of Bioidentical Hormones?

The side effects of bioidentical hormones match those of any estrogen, progesterone or testosterone therapy at the same dose. Most are mild and settle within the first few months or after a dose change.

• Estradiol: breast tenderness, bloating, headaches, nausea and irregular spotting, especially in the first three months.
• Progesterone: drowsiness (which is why oral micronized progesterone is usually taken at bedtime), dizziness and mood changes in some women.
• Testosterone: acne, oily skin and unwanted hair growth in women; a rise in red blood cell count (hematocrit), acne and lower sperm production in men.
• Pellets: bruising, infection or pellet extrusion at the insertion site, and hormone levels that can run above range.

For a fuller list by hormone type, see our post on HRT side effects.

Who Is a Good Candidate for BHRT?

BHRT may be appropriate for:

• Women in perimenopause or early menopause experiencing hot flashes, night sweats, mood changes, sleep disruption, or vaginal symptoms.
• Women within 10 years of menopause onset (or under age 60) who want the potential cardiovascular and bone benefits of early HRT.
• Women with premature ovarian insufficiency (menopause before age 40), who need hormone replacement to prevent long-term bone and cardiovascular consequences.
• Men with confirmed testosterone deficiency and symptoms affecting quality of life.
• Postmenopausal women with hypoactive sexual desire who may benefit from low-dose testosterone.

BHRT may not be appropriate for women with a history of hormone-receptor-positive breast cancer, active liver disease, unexplained vaginal bleeding, or a recent stroke or heart attack. These situations require individualized risk assessment with a knowledgeable provider.

Women in the transition years can find symptom patterns and timing in our perimenopause guide. Starting systemic hormone therapy after age 60, or more than 10 years after the final period, carries higher absolute risks of stroke, clots and dementia according to the North American Menopause Society (2017), so the balance needs closer review.

Who Prescribes Bioidentical Hormones?

Bioidentical hormones are prescribed by gynecologists, family physicians and internists, endocrinologists, urologists for men, and nurse practitioners and physician assistants working in menopause, men’s health and functional medicine practices. Some clinicians hold a menopause practitioner credential from the North American Menopause Society, now called The Menopause Society.

A well run BHRT practice confirms the diagnosis with history and blood tests, explains whether a product is FDA approved or compounded, offers transdermal estradiol when clot risk matters, prescribes a progestogen for women with a uterus, and schedules follow-up labs.

How Much Does BHRT Cost, and Does Insurance Cover It?

Cost depends mostly on whether the product is FDA approved. Many insurance plans cover FDA-approved bioidentical estradiol and micronized progesterone as ordinary prescriptions, and generic versions are widely available. Compounded creams, troches and estradiol pellets are usually not covered, so patients pay cash for the hormones as well as for the visits, lab panels and insertion procedures.

Prices vary widely by clinic and region, so ask for a written breakdown of consult, lab, product and follow-up fees before starting. Our post on what TRT costs walks through the same questions for men’s testosterone programs.

How to Find a BHRT Provider Near You

Regenerated.com lists clinics that offer hormone therapy in the national HRT and BHRT clinic directory, with city and state pages such as hormone therapy clinics in Florida. The directory is free for patients. Listing order is not paid ranking, Featured slots are labeled and capped, and Verified means the clinic completed credential checks, not that it spent more. Inclusion is not an endorsement, so bring the questions in the next section to any first consult. Our explainer on Featured, Verified and organic listings covers how each label works.

What to Expect From Treatment

If you decide to pursue BHRT, here’s what the process typically looks like:

Initial evaluation: A thorough history, symptom assessment, and baseline lab work. For women, this usually includes estradiol, progesterone, FSH, testosterone (total and free), DHEA-S, thyroid panel, and a metabolic panel. For men, total and free testosterone, SHBG, estradiol, LH, FSH, PSA, CBC, and a lipid panel. If you want those numbers in hand before a first appointment, the European longevity service BioProfile runs a doctor-reviewed panel that covers hormones, thyroid and metabolic markers.

For women over 45 with typical symptoms, the North American Menopause Society notes that menopause is usually diagnosed from symptoms and menstrual history, and hormone levels mainly help when the picture is unclear. Thyroid problems can mimic menopause, which is why a thyroid panel belongs in the workup.

Choosing a delivery method: Your provider should discuss the pros and cons of each option based on your health history, lifestyle, and preferences.

Starting low: Most experienced clinicians start with conservative doses and titrate upward based on symptom response and follow-up labs. “Start low, go slow” reduces side effects and allows for fine-tuning.

Follow-up monitoring: Expect lab work at 4 to 8 weeks after starting or adjusting a dose, then every 3 to 6 months once stable. Symptom tracking is just as important as lab numbers. A hormone level that looks “perfect” on paper doesn’t matter if you still feel terrible.

Ongoing assessment: BHRT isn’t something you set and forget. Your needs change over time, and regular reassessment ensures you’re getting benefit without unnecessary risk. Annual breast exams, mammograms, and cardiovascular screening should continue as recommended for your age group.

Questions to ask before starting BHRT

1. Is each hormone you are prescribing FDA approved, or compounded, and why?
2. Which route do you recommend for my clot and heart risk, and why?
3. If I have a uterus, which progestogen will protect it, and at what dose?
4. Which blood tests will you order, and when will they be repeated?
5. What is the full cost of consults, labs, products and follow-up visits?
6. How will we decide whether to continue, adjust or stop treatment?

Frequently asked questions

What are the benefits and risks of bioidentical hormone replacement therapy?

The benefits of bioidentical hormone replacement therapy are fewer hot flashes and night sweats, better sleep, relief of vaginal dryness and protection against bone loss, plus restored testosterone in men with confirmed deficiency. The risks are blood clots and stroke with oral estrogen, endometrial cancer if estrogen is taken without a progestogen by women with a uterus, and a breast cancer signal that appears smaller with micronized progesterone than with synthetic progestins.

Are bioidentical hormones safer than regular HRT?

Bioidentical hormones are not automatically safer than conventional HRT. FDA-approved bioidentical estradiol and micronized progesterone may carry lower clot and breast cancer risks than oral conjugated estrogens with synthetic progestins, mainly because of the transdermal route and the progestogen used. Compounded bioidentical hormones have no safety advantage according to the Endocrine Society (2016) and the National Academies (2020), and their doses can vary from batch to batch.

Is BHRT FDA approved?

Some BHRT is FDA approved and some is not. Estradiol patches, gels, sprays, tablets and vaginal rings and oral micronized progesterone are FDA-approved bioidentical hormones, as are testosterone products for men. Custom compounded creams, troches, estriol preparations and estradiol pellets are not FDA approved, because compounding pharmacies prepare them for individual prescriptions without the testing that approved drugs go through. No testosterone product is FDA approved for women.

How long does it take for bioidentical hormones to work?

Bioidentical estradiol usually starts easing hot flashes and night sweats within a few weeks, with full effect by about 8 to 12 weeks, according to the randomized trials behind the Cochrane review by MacLennan and colleagues (2004). Vaginal estrogen for dryness often takes several weeks of regular use. Testosterone effects on libido and energy in men build over weeks to months, and doses are usually adjusted after follow-up labs at 4 to 8 weeks.

Who should not take bioidentical hormones?

Bioidentical hormones are generally avoided by women with hormone-receptor-positive breast cancer, unexplained vaginal bleeding, active liver disease, or a recent stroke, heart attack or blood clot. Women who start systemic therapy after age 60 or more than 10 years past menopause face higher absolute risks, according to the North American Menopause Society (2017). Men with prostate or breast cancer, or untreated severe sleep apnea, are usually not candidates for testosterone.

Does insurance cover bioidentical hormone therapy?

Insurance often covers FDA-approved bioidentical hormones, such as estradiol patches and oral micronized progesterone, as standard prescriptions, subject to each plan’s formulary. Compounded bioidentical hormones and most estradiol pellet programs are usually not covered, so patients pay cash for products, visits and labs. Ask the clinic for a written fee breakdown and check with your insurer before the first appointment so the total cost is clear.

The Bottom Line

Bioidentical hormone therapy is a legitimate, evidence-backed treatment for hormone deficiency and menopause symptoms. It does not suit everyone, and it is not without risks. But when prescribed thoughtfully, monitored carefully, and delivered through appropriate methods, BHRT can meaningfully improve quality of life for the right patients.

The key is finding a provider who understands the nuances: bioidentical vs. synthetic, oral vs. transdermal, compounded vs. FDA-approved. These details matter more than most people realize, and getting them right is the difference between good outcomes and avoidable problems.

For a broader look at hormone replacement options and how they fit into a regenerative health approach, visit our Hormone Replacement Therapy pillar page.

Sources

1. Files JA, Ko MG, Pruthi S. Bioidentical hormone therapy. Mayo Clin Proc. 2011;86(7):673-680. doi:10.4065/mcp.2010.0714 ↩
2. Glaser R, Kalantaridou S, Engel D. Subcutaneous testosterone-estradiol implants in the treatment of premenopausal women with hormone-responsive cancers. Maturitas. 2013;76(2):177-181. doi:10.1016/j.maturitas.2013.07.007 ↩
3. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840-845. doi:10.1161/CIRCULATIONAHA.106.642280 ↩
4. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728-753. doi:10.1097/GME.0000000000000921 ↩
5. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;(4):CD002978. doi:10.1002/14651858.CD002978.pub2 ↩
6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288(3):321-333. doi:10.1001/jama.288.3.321 ↩
7. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229 ↩
8. Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. doi:10.1210/jc.2019-01603 ↩
9. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. doi:10.1007/s10549-007-9523-x ↩
10. Santoro N, Braunstein GD, Butts CL, et al. Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2016;101(4):1318-1343. doi:10.1210/jc.2016-1271 ↩

Related Reading

• Hormone Replacement Therapy: The Complete Guide
• HRT for Menopause: Types, Benefits, Risks, and How to Decide
• TRT Side Effects: What to Watch For
• How Much Does TRT Cost?
• Hashimoto’s Symptoms: What Your Thyroid Is Trying to Tell You